Clinical trial
Addressing Non-Initiation of Recommended Adjuvant Endocrine Therapy With a Culturally Informed-Intervention
NCT05465408 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Addressing Non-Initiation of Recommended Adjuvant Endocrine Therapy With a Culturally Informed-Intervention
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 21, 2022
- Completion date
- November 20, 2024
- Enrollment
- 35 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, survivorship, treatment adherence, treatment compliance, treatment refusal